Browsing Harvard-MIT Division of Health Sciences and Technology by Title
Research and Teaching Output of the MIT Community
- Home
- →
- Harvard-MIT Division of Health Sciences and Technology
- →
- Browsing Harvard-MIT Division of Health Sciences and Technology by Title
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Harvard-MIT Division of Health Sciences and Technology by Title
-
(Massachusetts Institute of Technology, 2009)Corporate spin-outs have become more frequent in the contemporary business environment as an alternate source of risk diversification and value creation for both the parent and external investors. Once established, corporate ...
-
(Massachusetts Institute of Technology, 2007)Companies must receive marketing authorization by the Food and Drug Administration (FDA) before they can begin commercial distribution of a new type of medical device in the United States. The premarket approval application ...
-
(Massachusetts Institute of Technology, 2005)Executive Summary: In this thesis, I examine faculty inventors' involvement in university spin-off firms formed to commercialize their inventions. In particular, I analyze the association between a faculty inventor's various ...
-
(Massachusetts Institute of Technology, 1996)
-
(Massachusetts Institute of Technology, 2009)Many early-stage biotech companies face a significant funding gap when trying to develop a new drug from preclinical development to a proof of concept clinical trial. This funding gap is sometimes referred to as the "valley ...
-
(Massachusetts Institute of Technology, 2010)Genetic testing companies have come under fire lately for an array of reasons. Many direct-to-consumer outfits are being challenged by the federal regulatory authorities, by the physicians' community and by the public ...
-
(Massachusetts Institute of Technology, 1996)
-
(Massachusetts Institute of Technology, 1990)
-
(Massachusetts Institute of Technology, 2007)The overall goal of this research is to acquire a more complete picture of the neurological processes of visual influences on speech perception and to investigate effects of hearing status on AV speech perception. More ...
-
(Massachusetts Institute of Technology, 1991)
-
(Massachusetts Institute of Technology, 1996)
-
(Massachusetts Institute of Technology, 2012)Successful translation of scientific discovery into new medicines is most successful with collaboration between academics - scientists and physicians - and industry. In recent years, there has been increasing concern at ...
-
(Massachusetts Institute of Technology, 2011)Herceptin was the poster child of personalized medicine that brought forward the notion that contemporaneously developed companion diagnostics (CDx) could lead to more efficacious use of a cancer therapeutic in a selected ...
-
(Massachusetts Institute of Technology, 2002)Our lab's long-term goal is to elucidate the circuitry of the visual cortex, to develop quantitative computational models of neuronal function in the visual cortex, and to establish how these models may relate to visual ...
-
Functional and molecular characterization of the vascular endothelial response to fluid shear stress (Massachusetts Institute of Technology, 1994)
-
(Massachusetts Institute of Technology, 1998)
-
(Massachusetts Institute of Technology, 2008)Sound-evoked vibrations transmitted into the mammalian cochlea produce traveling waves that provide the mechanical tuning necessary for spectral decomposition of sound. These traveling waves of motion propagate along the ...
-
(Massachusetts Institute of Technology, 2005)Imaging speed in conventional magnetic resonance imaging (MRI) is limited by the performance of magnetic field gradients and the rate of power deposition in tissue. Parallel MRI techniques overcome these constraints by ...
-
(Massachusetts Institute of Technology, 2011)Autocrine signaling plays essential roles in providing self-sustaining growth signals to cancer cells. Since the introduction of the autocrine hypothesis in 1980s, the contribution of autocrine signaling in cancer medicine ...
-
(Massachusetts Institute of Technology, 2007)It has been widely reported that pharmaceutical drug discovery innovation began its major decline somewhere in the last decade of the 20th century. After reaching a historical high of 53 new molecular entities (NMEs) in ...
Browse
My Account
MIT-Mirage